Dale Thomas, Mytide cofounder, and Errik Anderson, Alloy Therapeutics CEO
March 8, 2022 08:28 AM ESTUpdated 11:58 AM
Financing
Pharma
Manufacturing

With in­vest­ment from Al­loy, Boston pep­tide man­u­fac­tur­er an­nounces Se­ries A

Josh Sullivan

In an ide­al sce­nario, Mytide Ther­a­peu­tics co-founder Dale Thomas pic­tures his com­pa­ny’s tech in hos­pi­tals across Amer­i­ca. On Tues­day, the com­pa­ny an­nounced a $7 mil­lion …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Up­dat­ed: CEO of Unit­ed­Health in­sur­ance unit shot and killed in New York in what po­lice call ‘a brazen, tar­get­ed ...

Blue­bird and Ver­tex's sick­le cell gene ther­a­pies to kick off new Med­ic­aid ac­cess mod­el

Lil­ly beats No­vo in bell­wether head-to-head weight loss study

As 23andMe strug­gles, an­oth­er ge­net­ic test­ing com­pa­ny bets on drug dis­cov­ery

Mod­er­na CEO de­fends pan­dem­ic prep ef­forts with crit­ics set to en­ter Trump’s ad­min­is­tra­tion

Trade group tells FDA that semaglu­tide is not too 'com­plex' for com­pound­ing

A service from the Financial Times